FDA approves Dainippon's Aptiom for seizures

FDA approved an NDA from the Sunovion Pharmaceuticals Inc. subsidiary of Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506) for Aptiom eslicarbazepine (formerly Stedesa) as an add-on therapy to treat par...